About PharmaCon Asia


Global or local? COVID-19 has highlighted the need to update the pharma supply chain. From manufacturing to distribution of medicines, the global supply chain has enabled the industry to reach economies of scale and make essential drugs available and affordable for many patients.

However, it’s also made it vulnerable to bottlenecks such as the complex tangle of systems and processes across different countries creating a domino effect that delays production and exacerbated by the pandemic as the demand outruns the supply.

As the dust is still settling from the pandemic, stakeholders across the ecosystem are looking to re-strategize and work more closely together to build new strengths in the supply chain to tackle this among other emerging and permanent shifts in healthcare.

With a local and regional focus on Singapore and Asia-Pacific, the 8th Annual PharmaCon Asia will look at rewriting pharma’s rules and collaborating for a sustainable future. The event will bring together bring together pharma manufacturers, the biotech/startup-VC ecosystem, technology and service providers, and government stakeholders of every level to address current trends and prospects shaping the future of the industry.

THIS IS A FORUM DESIGNED TO CONVENE KEY DECISION-MAKERS IN PHARMA. CO-LOCATING:

The event will be hybrid – delivered both live, on-site at Farrer Park Hotel, Singapore*, and live-streamed on Swapcard for the Clinical Trials’ track.

Switch between the sessions you want to attend, engage in intimate networking opportunities through lunch roundtables, pitch fests and panel discussions. Don’t miss out on this one-stop platform to learn, meet, and network with Asia’s pharmaceutical sector!

*Please note that the live, on-site event is still pending approval from Singapore Tourism Board (STB). Click here for Informa’s COVID-19 Advisory

AGENDA AT A GLANCE

Main Conference Day 1
Tues, 5th Oct

Plenary Sessions:
International Pharma Manufacturer/Biotech Keynote
Panel Discussion

Clinical Trials
Live, On-Site & Live-Streamed on Swapcard

  • Trial opportunity spotlights on oncology, vaccines, immune-oncology & infectious diseases
  • Navigating diverse regulations in APAC
  • Streamlining outsourcing strategy & partnership/business models
  • Tech in trials – Virtual trials, wearables, etc.
  • Site & investigator engagement

Market Access
Live, On-Site

  • Regulatory, procurement, & strategic pricing roadmap
  • Adapting commercialization strategies in light of COVID-19
  • Contracting & payment models
  • Regional case studies on access & affordability

Regulatory Affairs
Live, On-Site

  • Asia OTC regulatory strategy development
  • Supply chain, labelling & packaging
  • Regulatory strategy on data protection & privacy in the digital age
  • CMC variations in the region & managing complications
  • Impacts of COVID-19 against pharma competition law

EXCLUSIVE FOR LIVE, ON-SITE ATTENDEES!
Collaboration For Innovation: Singapore-based biotechs sharing of best practices in clinical trials & networking.

End of Day 1

Main Conference Day 2
Wed, 6th Oct

Plenary Sessions:
International Pharma Manufacturer/Biotech Keynote
Panel Discussion

Clinical Trials
Live, On-Site & Live-Streamed on Swapcard

  • CRO partnership – Cost control, oversight management, regulatory strategy & risk management
  • Operational cost controls, recruitment, & site selection
  • Building patient-centric clinical trial design
  • Trials of the future
  • Startup ecosystem for innovating clinical trials

Market Access
Live, On-Site

  • Regulatory, procurement, & strategic pricing roadmap
  • Adapting commercialization strategies in light of COVID-19
  • Contracting & payment models
  • Regional case studies on access & affordability

Regulatory Affairs
Live, On-Site

  • Asia OTC regulatory strategy development
  • Supply chain, labelling & packaging
  • Regulatory strategy on data protection & privacy in the digital age
  • CMC variations in the region & managing complications
  • Impacts of COVID-19 against pharma competition law

End of Conference

SELECT PHARMA MANUFACTURERS & REGULATORS CAN ATTEND OUR EVENTS FOR FREE AS VIP GUESTS!

We believe it is important to nurture our relationships with our most loyal partners, we are offering a limited number of free VIP tickets to selected pharma manufacturers and regulators.

2020 attendee pharma manufacturers include GSK, Roche, Pfizer, Takeda, Dr. Reddy’s, and more.

ARE YOU ELIGIBLE?

Passes are limited and subject to verification by the Informa Connect team. Eligible job titles include:

  • CEO, President
  • Assistant/Senior Vice-President
  • Managing Director
  • Country Director
  • Medical Director
  • Chief Medical Officer, Chief Scientific Officer
  • Head of Departments
  • Lead (Digital/Innovation, Clinical Trials, Commercialization, Market Access, Regulatory Affairs)
  • Managing Partner
  • Senior Manager (Investments)

You can apply for your VIP ticket here.

WHO YOU WILL MEET (%)

By Region

  • Singapore
  • Malaysia
  • South East Asia
  • North Asia
  • Europe and Australia
  • Rest of the world

By Industry

  • pharmaceutical Companies
  • Technology Providers
  • Contract Manufacturing Organizations
  • Financial Advisory and Healthcare Consultant
  • Government Agencies

PAST EVENT PHOTOS